Cart
sales@molnova.com
Clausine E
CAS No. 182261-83-2
Clausine E ( —— )
Catalog No. M23829 CAS No. 182261-83-2
Clausine E is an inhibitor of fat mass and obesity-associated protein (FTO) demethylase activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 342 | In Stock |
|
| 10MG | 509 | In Stock |
|
| 25MG | 801 | In Stock |
|
| 50MG | 1107 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameClausine E
-
NoteResearch use only, not for human use.
-
Brief DescriptionClausine E is an inhibitor of fat mass and obesity-associated protein (FTO) demethylase activity.
-
DescriptionClausine E is an inhibitor of fat mass and obesity-associated protein (FTO) demethylase activity. The binding of Clausine E to FTO was driven by positive entropy and negative enthalpy changes.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFTO
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number182261-83-2
-
Formula Weight241.2
-
Molecular FormulaC14H11NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC(c1cc(O)c2[nH]c(cccc3)c3c2c1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang Y, et al. Identification of Clausine E as an inhibitor of fat mass and obesity-associated protein (FTO) demethylase activity. J Mol Recognit. 2019 Oct;32(10):e2800.
molnova catalog
related products
-
5-TAMRA chloride(918...
5-TAMRA can produce bright, pH insensitive orange fluorescence (Ex/ Em= 546 / 579nm), and has good photostability
-
Carpachromene
Carpachromene could be a potential anti-inflammatory agent, it blocks protein expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated macrophages.Carpachromene shows significant α-glucosidase inhibitory activity.
-
Temozolomide Acid
Temozolomide Acid is a metabolite of temozolomide (TMZ). Temozolomide processes anticancer activity in vitro. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas.
